$BIIB Company News Utility stocks gain as Treasu
Post# of 44997
Posted On: 02/13/2014 11:50:04 AM
$BIIB Company News
Utility stocks gain as Treasury yields lag 4:06 p.m. Feb. 4, 2014 - Wallace Witkowski
Biogen Idec investors focus on positive, ignore outlook for 2014 2:02 p.m. Jan. 29, 2014 - blogs.marketwatch.com
Biogen profit jumps on MS treatment revenue 7:09 a.m. Jan. 29, 2014 - MarketWatch.com
Stock investors trash market darlings, face Apple, Fed 8:00 a.m. Jan. 26, 2014 - Wallace Witkowski
The market puts a few feathers in its cap 1:58 p.m. Jan. 23, 2014 - The Trading Deck
Speculators turn the heat up to ‘soft boil’ 3:54 p.m. Jan. 16, 2014 - The Trading Deck
GameStop tumbles 20%; Tesla surges on strong sales 4:22 p.m. Jan. 14, 2014 - Ben Eisen
Beam up on Suntory deal; Elliott report lifts Juniper 4:17 p.m. Jan. 13, 2014 - Saumya Vaishampayan
Biogen, Sangamo partner on hemoglobin therapies 9:38 a.m. Jan. 9, 2014 - MarketWatch.com
Earnings boost Micron, drag on Container Store 4:24 p.m. Jan. 8, 2014 - Ben Eisen
Goldman's biotech downgrade and the new consensus 11:53 a.m. Jan. 6, 2014 - MarketWatch.com
Charting a bullish year-end backdrop 12:28 p.m. Dec. 17, 2013 - Michael Ashbaugh
Charting a bullish year-end backdrop 12:03 p.m. Dec. 17, 2013 - Michael Ashbaugh
Get your portfolio to turn the corner 2:32 p.m. Dec. 10, 2013 - The Trading Deck
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Growth stock players should reduce expectations 1:18 p.m. Nov. 26, 2013 - The Trading Deck
DaVita, Fresenius gain; energy firms slip 4:55 p.m. Nov. 25, 2013 - Ben Eisen
Stocks gain for 7th week; S&P ends above 1,800 4:24 p.m. Nov. 22, 2013 - Polya Lesova
Biogen Idec jumps; Intel, Ross Stores slide 4:23 p.m. Nov. 22, 2013 - Ben Eisen
Biogen surges 13%, best on S&P 500 9:33 a.m. Nov. 22, 2013 - Laura Mandaro
Isis to get another $9M from Biogen 9:15 a.m. Today - Seeking Alpha
What Makes Genomic Health (GHDX) a Strong Sell? - Tale of the Tape 8:45 a.m. Today - Zacks.com
Biogen Idec Inc (BIIB): Today's Featured Drugs Winner 5:00 p.m. Feb. 12, 2014 - TheStreet.com
Drugs Stocks On The Rise With Help From 5 Stocks 12:02 p.m. Feb. 12, 2014 - TheStreet.com
Biotech Stock Roundup: Gilead's Sovaldi Impresses, EU Nod for Biogen's Tecfidera - Analyst Blog 8:27 a.m. Feb. 12, 2014 - Zacks.com
Data on Repros' Androxal - Analyst Blog 6:26 p.m. Feb. 11, 2014 - Zacks.com
NewLink Genetics (NLNK) Jumps: Stock Rises 8.3% - Tale of the Tape 9:21 a.m. Feb. 11, 2014 - Zacks.com
Sunesis Pharmaceuticals (SNSS) Falls: Stock Goes Down 5.4% - Tale of the Tape 8:58 a.m. Feb. 11, 2014 - Zacks.com
Scary, Overpriced Market? Here's 20 Odds-On Winners 5:44 a.m. Feb. 11, 2014 - Seeking Alpha
Puma Biotech Surges on Favorable Patent Ruling - Analyst Blog 5:35 p.m. Feb. 10, 2014 - Zacks.com
Gap-Ups Point To Strength Among Select Big Caps 4:35 p.m. Feb. 10, 2014 - Investors Business Daily
Affymetrix Slips to Hold - Analyst Blog 3:30 p.m. Feb. 10, 2014 - Zacks.com
Why You Need to Pay Attention to Cambrex Corporation. (CBM) Stock? - Tale of the Tape 8:59 a.m. Feb. 10, 2014 - Zacks.com
Three ETFs To Buy On The Pullback (PJP, SKYY, SPY) 8:13 a.m. Feb. 10, 2014 - Benzinga.com
Worried About A Market Meltdown? Consider This. 3:08 a.m. Feb. 10, 2014 - Seeking Alpha
Weekly 52-Week Highs Highlight: ORLY, LLL, BIIB, NVS 9:02 p.m. Feb. 9, 2014 - GuruFocus.com
EU Approval Widens Reach For Biogen Drug 5:31 p.m. Feb. 7, 2014 - Investors Business Daily
FDA to Review Spectrum Pharma' Beleodaq - Analyst Blog 5:00 p.m. Feb. 7, 2014 - Zacks.com
Biogen Idec (BIIB) On Momo Momentum Watch Today 11:59 a.m. Feb. 7, 2014 - TheStreet.com
Teva Beats on Q4 Earnings & Revs, Affirms View - Analyst Blog 9:10 a.m. Feb. 7, 2014 - Zacks.com
Isis Pharmaceuticals Advances ISIS-SMN Rx in Infants and Children with Spinal Muscular Atrophy 7:00 a.m. Today - PR Newswire - PRF
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
RBCC Seeks Out Capital Partners for 3D Bioprinting Expansion 5:00 a.m. Feb. 6, 2014 - BusinessWire - BZX
Cleave Biosciences Names Alessandra Cesano as Chief Medical Officer and Lewis Shuster as Director 8:00 a.m. Feb. 4, 2014 - PR Newswire - PRF
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis 9:33 a.m. Feb. 3, 2014 - BusinessWire - BZX
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis 8:53 a.m. Feb. 3, 2014 - BusinessWire - BZX
RBCC: 3D Bioprinting Tech Ushers in Future of Medicine 8:40 a.m. Feb. 3, 2014 - BusinessWire - BZX
Ignyta Appoints Matthew Onaitis as General Counsel 7:00 a.m. Feb. 3, 2014 - BusinessWire - BZX
Biogen Idec Foundation Awards Museum of Science $2.5 Million to Support Hall of Human Life 8:30 a.m. Jan. 30, 2014 - BusinessWire - BZX
Biogen Idec and UCB Enter Agreements to Commercialize Multiple Sclerosis and Hemophilia Therapies in Asia 1:00 a.m. Jan. 30, 2014 - BusinessWire - BZX
Biogen Idec 2013 Total Revenues Increase 26 Percent to $6.9 Billion 6:30 a.m. Jan. 29, 2014 - BusinessWire - BZX
RBCC Develops Innovations in White-Hot 3D Bioprinting Sector 4:00 a.m. Jan. 27, 2014 - BusinessWire - BZX
RXI Pharmaceuticals Could Benefit from Biotech Industry Dynamics 10:06 a.m. Jan. 24, 2014 - ACCESSWIRE
Critical Alerts For General Electric, SodaStream, Biogen Idec, Linn Energy, and Allscripts Released By InvestorsObserver 9:31 a.m. Jan. 24, 2014 - PR Newswire - PRF
RBCC Moves to the Front Lines of the 3D Bioprinting Revolution 5:00 a.m. Jan. 20, 2014 - BusinessWire - BZX
RBCC Prepares Big Push Into Booming 3D Bioprinting Market 5:00 a.m. Jan. 16, 2014 - BusinessWire - BZX
Biogen Idec to Report Fourth Quarter and Year-End 2013 Financial Results on January 29, 2014 4:01 p.m. Jan. 15, 2014 - BusinessWire - BZX
RBCC Partner Therakine Presents Novel Drug Delivery Technology at Biotech Showcase 5:00 a.m. Jan. 15, 2014 - BusinessWire - BZX
Biogen Idec Announces Availability of FAMPYRA® in Ireland to Treat Walking Impairment in Adults with Multiple Sclerosis 4:00 a.m. Jan. 15, 2014 - BusinessWire - BZX
Leading Life Sciences CEOs Honor Johnson & Johnson Chief Scientific Officer Paul Stoffels with Lifetime Achievement Award at Annual East/West CEO Conference 9:49 a.m. Jan. 14, 2014 - BusinessWire - BZX
Utility stocks gain as Treasury yields lag 4:06 p.m. Feb. 4, 2014 - Wallace Witkowski
Biogen Idec investors focus on positive, ignore outlook for 2014 2:02 p.m. Jan. 29, 2014 - blogs.marketwatch.com
Biogen profit jumps on MS treatment revenue 7:09 a.m. Jan. 29, 2014 - MarketWatch.com
Stock investors trash market darlings, face Apple, Fed 8:00 a.m. Jan. 26, 2014 - Wallace Witkowski
The market puts a few feathers in its cap 1:58 p.m. Jan. 23, 2014 - The Trading Deck
Speculators turn the heat up to ‘soft boil’ 3:54 p.m. Jan. 16, 2014 - The Trading Deck
GameStop tumbles 20%; Tesla surges on strong sales 4:22 p.m. Jan. 14, 2014 - Ben Eisen
Beam up on Suntory deal; Elliott report lifts Juniper 4:17 p.m. Jan. 13, 2014 - Saumya Vaishampayan
Biogen, Sangamo partner on hemoglobin therapies 9:38 a.m. Jan. 9, 2014 - MarketWatch.com
Earnings boost Micron, drag on Container Store 4:24 p.m. Jan. 8, 2014 - Ben Eisen
Goldman's biotech downgrade and the new consensus 11:53 a.m. Jan. 6, 2014 - MarketWatch.com
Charting a bullish year-end backdrop 12:28 p.m. Dec. 17, 2013 - Michael Ashbaugh
Charting a bullish year-end backdrop 12:03 p.m. Dec. 17, 2013 - Michael Ashbaugh
Get your portfolio to turn the corner 2:32 p.m. Dec. 10, 2013 - The Trading Deck
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Growth stock players should reduce expectations 1:18 p.m. Nov. 26, 2013 - The Trading Deck
DaVita, Fresenius gain; energy firms slip 4:55 p.m. Nov. 25, 2013 - Ben Eisen
Stocks gain for 7th week; S&P ends above 1,800 4:24 p.m. Nov. 22, 2013 - Polya Lesova
Biogen Idec jumps; Intel, Ross Stores slide 4:23 p.m. Nov. 22, 2013 - Ben Eisen
Biogen surges 13%, best on S&P 500 9:33 a.m. Nov. 22, 2013 - Laura Mandaro
Isis to get another $9M from Biogen 9:15 a.m. Today - Seeking Alpha
What Makes Genomic Health (GHDX) a Strong Sell? - Tale of the Tape 8:45 a.m. Today - Zacks.com
Biogen Idec Inc (BIIB): Today's Featured Drugs Winner 5:00 p.m. Feb. 12, 2014 - TheStreet.com
Drugs Stocks On The Rise With Help From 5 Stocks 12:02 p.m. Feb. 12, 2014 - TheStreet.com
Biotech Stock Roundup: Gilead's Sovaldi Impresses, EU Nod for Biogen's Tecfidera - Analyst Blog 8:27 a.m. Feb. 12, 2014 - Zacks.com
Data on Repros' Androxal - Analyst Blog 6:26 p.m. Feb. 11, 2014 - Zacks.com
NewLink Genetics (NLNK) Jumps: Stock Rises 8.3% - Tale of the Tape 9:21 a.m. Feb. 11, 2014 - Zacks.com
Sunesis Pharmaceuticals (SNSS) Falls: Stock Goes Down 5.4% - Tale of the Tape 8:58 a.m. Feb. 11, 2014 - Zacks.com
Scary, Overpriced Market? Here's 20 Odds-On Winners 5:44 a.m. Feb. 11, 2014 - Seeking Alpha
Puma Biotech Surges on Favorable Patent Ruling - Analyst Blog 5:35 p.m. Feb. 10, 2014 - Zacks.com
Gap-Ups Point To Strength Among Select Big Caps 4:35 p.m. Feb. 10, 2014 - Investors Business Daily
Affymetrix Slips to Hold - Analyst Blog 3:30 p.m. Feb. 10, 2014 - Zacks.com
Why You Need to Pay Attention to Cambrex Corporation. (CBM) Stock? - Tale of the Tape 8:59 a.m. Feb. 10, 2014 - Zacks.com
Three ETFs To Buy On The Pullback (PJP, SKYY, SPY) 8:13 a.m. Feb. 10, 2014 - Benzinga.com
Worried About A Market Meltdown? Consider This. 3:08 a.m. Feb. 10, 2014 - Seeking Alpha
Weekly 52-Week Highs Highlight: ORLY, LLL, BIIB, NVS 9:02 p.m. Feb. 9, 2014 - GuruFocus.com
EU Approval Widens Reach For Biogen Drug 5:31 p.m. Feb. 7, 2014 - Investors Business Daily
FDA to Review Spectrum Pharma' Beleodaq - Analyst Blog 5:00 p.m. Feb. 7, 2014 - Zacks.com
Biogen Idec (BIIB) On Momo Momentum Watch Today 11:59 a.m. Feb. 7, 2014 - TheStreet.com
Teva Beats on Q4 Earnings & Revs, Affirms View - Analyst Blog 9:10 a.m. Feb. 7, 2014 - Zacks.com
Isis Pharmaceuticals Advances ISIS-SMN Rx in Infants and Children with Spinal Muscular Atrophy 7:00 a.m. Today - PR Newswire - PRF
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
RBCC Seeks Out Capital Partners for 3D Bioprinting Expansion 5:00 a.m. Feb. 6, 2014 - BusinessWire - BZX
Cleave Biosciences Names Alessandra Cesano as Chief Medical Officer and Lewis Shuster as Director 8:00 a.m. Feb. 4, 2014 - PR Newswire - PRF
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis 9:33 a.m. Feb. 3, 2014 - BusinessWire - BZX
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis 8:53 a.m. Feb. 3, 2014 - BusinessWire - BZX
RBCC: 3D Bioprinting Tech Ushers in Future of Medicine 8:40 a.m. Feb. 3, 2014 - BusinessWire - BZX
Ignyta Appoints Matthew Onaitis as General Counsel 7:00 a.m. Feb. 3, 2014 - BusinessWire - BZX
Biogen Idec Foundation Awards Museum of Science $2.5 Million to Support Hall of Human Life 8:30 a.m. Jan. 30, 2014 - BusinessWire - BZX
Biogen Idec and UCB Enter Agreements to Commercialize Multiple Sclerosis and Hemophilia Therapies in Asia 1:00 a.m. Jan. 30, 2014 - BusinessWire - BZX
Biogen Idec 2013 Total Revenues Increase 26 Percent to $6.9 Billion 6:30 a.m. Jan. 29, 2014 - BusinessWire - BZX
RBCC Develops Innovations in White-Hot 3D Bioprinting Sector 4:00 a.m. Jan. 27, 2014 - BusinessWire - BZX
RXI Pharmaceuticals Could Benefit from Biotech Industry Dynamics 10:06 a.m. Jan. 24, 2014 - ACCESSWIRE
Critical Alerts For General Electric, SodaStream, Biogen Idec, Linn Energy, and Allscripts Released By InvestorsObserver 9:31 a.m. Jan. 24, 2014 - PR Newswire - PRF
RBCC Moves to the Front Lines of the 3D Bioprinting Revolution 5:00 a.m. Jan. 20, 2014 - BusinessWire - BZX
RBCC Prepares Big Push Into Booming 3D Bioprinting Market 5:00 a.m. Jan. 16, 2014 - BusinessWire - BZX
Biogen Idec to Report Fourth Quarter and Year-End 2013 Financial Results on January 29, 2014 4:01 p.m. Jan. 15, 2014 - BusinessWire - BZX
RBCC Partner Therakine Presents Novel Drug Delivery Technology at Biotech Showcase 5:00 a.m. Jan. 15, 2014 - BusinessWire - BZX
Biogen Idec Announces Availability of FAMPYRA® in Ireland to Treat Walking Impairment in Adults with Multiple Sclerosis 4:00 a.m. Jan. 15, 2014 - BusinessWire - BZX
Leading Life Sciences CEOs Honor Johnson & Johnson Chief Scientific Officer Paul Stoffels with Lifetime Achievement Award at Annual East/West CEO Conference 9:49 a.m. Jan. 14, 2014 - BusinessWire - BZX
(0)
(0)